Back to Agenda
Health Care's Revolutionary Printing Press? 3D Printing - Blue Sky and Regulatory Path
Session Chair(s)
Nancy Bradish Myers, JD
CEO and Founder, Catalyst Healthcare Consulting, United States
Disruptive technology and health care are not usually used in the same sentence. We don't hear "Let's print out a new drug" or "How about a new ear" every day either. While news articles have only speculated about how 3D printing could revolutionize drug discovery and tissue regeneration, the technology is already being used in certain areas of health care - for example, to create customized joint replacements. Come hear experts from the 3D printing world, regulatory officials, and industry leaders discuss the potential impact of 3D printing on drug discovery and health delivery, and the regulatory challenges the technology may face as it continues its advance into health care.
Learning Objective : Identify the ways in which 3D printing could change medical product development; Define the regulatory challenges associated with 3D printing, and potential approaches by regulators; Identify ways in which 3D printing may impact your organization.
Speaker(s)
Steven K. Pollack
Research Scientist, Carbon 3D, Inc. , United States
Scientific Policy on 3D Printers
Eric M. David, JD, MD
Co-Founder and Chief Strategy Officer, Organovo, Inc., United States
Industry Perspective
Brian M. Strem
Director, Business Development, Allergan, Inc., United States
Industry Perspective
Have an account?